Dirk Kersten, Director at Dyne Therapeutics, Inc. (DYN), sold 10,952 shares at $20.01 ($219K) on 2026-04-21, disclosed to the SEC on 2026-04-23.
Scheduled sale ($219k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.01 | 8,300 | $166K | 75.8% |
| 2 | $20.00 | 2,652 | $53K | 24.2% |
| Total | $20.01 avg | 10,952 | $219K | 100% |
| Filing → |
| DYN | SELL | 2026-06-22 | $1.7M | — | Filing → |
| DYN | SELL | 2026-04-21 | $6.8M | — | Filing → |
| DYN | SELL | 2026-04-17 | $2.0M | — | Filing → |